ARCHIVES

NCI Director Declines To Fund P-4 Breast Cancer Chemoprevention Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 24 | June 22, 2007

Download PDF Visit The Full Archive

Related Articles

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

NCI CTEP Approved Trials For the Month of March

March 29, 2013

DeVita Distressed Over “Misinformation” Circulation On Organ Systems Program

April 8, 1983

Rhoads Suggests Plan For 200 Clinical Centers

January 28, 1977

CMS Withholds Coverage of CT Colonography

May 15, 2009

NCI Looking At CCOP Budgets To Determine How Many Will Be Funded; Some Top Scorers Identified

March 13, 1987